Phaseline

Targets › GABRA1

GABRA1 (Gamma-aminobutyric acid receptor subunit alpha-1): drug programs, companies and trials

57 programs from 48 companies in 97 trials: 45 Phase 4, 20 Phase 3, 18 Phase 2, 14 Phase 1; Other, Psychiatry, Neurology; next expected readout Nov 2026.

Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain. GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s). (UniProt, P14867)

Open in Phaseline: the race on GABRA1, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Rush University Medical CenterMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Minor Surgical Procedures With Monitored Anesthesia CareNov 2026
Kaohsiung Medical University Chung-Ho Memorial HospitalPropofol
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Lung Cancer; Hepatocellular Carcinoma; Ovarian CancerNov 2026
Kaohsiung Medical University Chung-Ho Memorial HospitalSevoflurane
Glycine receptor (alpha-1/beta) positive modulator; GABA-A receptor; anion channel positive allosteric modulator; Potassium channel subfamily K member 10 opener
GLRA1, GLRB, GABRA1, GABRB2, GABRG2Phase 4Lung Cancer; Hepatocellular Carcinoma; Ovarian CancerNov 2026
University of Sao PauloEszopiclone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4InsomniaDec 2026
University Hospitals Cleveland Medical CenterValtoco Nasal Product
Benzodiazepine (diazepam) nasal spray for acute seizure management
GABRA1Phase 4EpilepsyDec 2026
VA Office of Research and DevelopmentZolpidem
GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator
GABRA1, GABRG2, GABRB1Phase 4Sleep Disordered BreathingDec 2026
Medical University of South CarolinaRemimazolam besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Burn ScarJan 2027
Rawalpindi Institute of CardiologyKetamine-Propofol
NMDA receptor antagonist combined with GABA-A agonist
NMDAR, GABRA1Phase 4PropofolJan 2027
Medical University of South CarolinaMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Anesthesia InductionApr 2027
Seoul National University HospitalRemimazolam Besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Remimazolam; Aortic Aneurysm, ThoracoabdominalApr 2027
SK Life ScienceCenobamate (YKP3089)
GABA-A receptor; anion channel positive allosteric modulator; Sodium channel alpha subunit inhibitor
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Focal Onset Seizure; Partial EpilepsyMay 2027
Clinical Hospital Centre ZagrebRemimazolam besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Colonic PolypNov 2027
Medical University of ViennaDesflurane
Glycine receptor (alpha-1/beta) positive modulator; GABA-A receptor; anion channel positive allosteric modulator; Potassium channel subfamily K member 10 opener
GLRA1, GLRB, GABRA1, GABRB2, GABRG2Phase 4Postoperative DeliriumDec 2027
Laureate Institute for Brain Research, Inc.Lorazepam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Depression, AnxietyDec 2027
David LyubashevskyMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Transcatheter Aortic Valve Replacement (TAVR)Apr 2028
University of Southern CaliforniaZolpidem Tartrate
GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator
GABRA1, GABRG2, GABRB1Phase 4Spine FusionJan 2029
VA Office of Research and DevelopmentLorazepam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Stress Disorders, Post-TraumaticJun 2029
Haisco Pharmaceutical GroupCipepofol (HSK3486)
GABA-A receptor; anion channel agonist
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Anesthesia; Myocardial Injury–
Xi'an Aerospace General HospitalCiprofol
GABA-A receptor positive allosteric modulator
GABRA1, GABRA2, GABRA3Phase 4Cholelithiasis–
Georgia TsaousiDesflurane
Glycine receptor (alpha-1/beta) positive modulator; GABA-A receptor; anion channel positive allosteric modulator; Potassium channel subfamily K member 10 opener
GLRA1, GLRB, GABRA1, GABRB2, GABRG2Phase 4Brain Edema Caused by Drugs–
Hui XuFospropofol disodium
Intravenous general anesthetic prodrug
GABRA1Phase 4Drug Safety–
University of OklahomaMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Laceration of Skin–
Universidade Federal de GoiasMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Child Behavior–
Beijing Shijitan Hospital, Capital Medical UniversityRemimazolam Besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Effect of Drug–
Xi'an Aerospace General HospitalRemimazolam besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Cholelithiasis–
University of California, Los AngelesCBD 20 mg
GABA-A receptor; anion channel positive allosteric modulator
HTR1A, GABRA1, GABRB2, GABRG2, GABRB3, GABRA4, SLC1A2, SLC1A3Phase 3Spinocerebellar Ataxias; Non-healing Wound; Sleep Apnea, Obstructive; Cervical Spinal Cord Injury …Dec 2026
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Laceration of SkinDec 2026
University of Texas Southwestern Medical CenterPropofol
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3AnesthesiaJan 2027
Ono PharmaceuticalCenobamate
GABA-A receptor; anion channel positive allosteric modulator; Sodium channel alpha subunit inhibitor
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Partial Epilepsy; Epilepsies, PartialJan 2027
Ono PharmaceuticalONO-2017
Sodium channel modulator; GABA-A receptor positive allosteric modulator
Ion channels, GABRA1Phase 3Epilepsy, GeneralizedJan 2027
Southeast University, ChinaRemimazolam besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Remimazolam BesylateJan 2027
UCB Biopharma SRLAlprazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Stereotypical Prolonged Seizures; Ophthalmology; Opioid Abuse; Drug InteractionsMar 2027
Emory UniversityZolpidem
GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator
GABRA1, GABRG2, GABRB1Phase 3Orthopedic TraumaJul 2027
LipocineBrexanolone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Depression, Postpartum; Alzheimer Dementia; PTSDAug 2027
University Hospital, MontpellierMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3AnesthesiaOct 2027
Xijing Hospitaldesflurane
Glycine receptor (alpha-1/beta) positive modulator; GABA-A receptor; anion channel positive allosteric modulator; Potassium channel subfamily K member 10 opener
GLRA1, GLRB, GABRA1, GABRB2, GABRG2Phase 3Cardiac SurgeryDec 2028
Yale UniversityEszopiclone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Sleep ApneaJan 2030
Sedana MedicalIsoflurane
Glycine receptor (alpha-1/beta) positive modulator; GABA-A receptor; anion channel positive allosteric modulator; Potassium channel subfamily K member 10 opener
GLRA1, GLRB, GABRA1, GABRB2, GABRG2Phase 3Post-Intensive Care Syndrome; Diabete Mellitus; Sedation; Prevention of Delirium …–
Stanford UniversityMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Seizures–
Romanian Society for Enteral and Parenteral NutritionRemimazolam Besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Postoperative Cognitive Dysfunction–
Neurodawn PharmaceuticalY-4
combination of pregabalin (GABA analog) and riluzole (glutamate release inhibitor)
GABRA1, SLCX1Phase 2Postherpetic NeuralgiaNov 2026
Seaport TherapeuticsSPT-300 (GlyphAllo)
Allopregnanolone prodrug; positive allosteric modulator of GABA-A receptors
GABRA1Phase 2Major Depressive Disorder (MDD)Mar 2027
University of California, Los AngelesIntravenous Alcohol (6% ethanol v/v in saline)
GABA-A receptor positive allosteric modulator; CNS depressant
GABRA1, GABRA2, GABRA3Phase 2Alcohol Use DisorderApr 2027
Flinders UniversityEszopiclone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2OSA - Obstructive Sleep ApneaMay 2027
Duke UniversityZuranolone
Neuroactive steroid; GABA receptor positive allosteric modulator
GABRA1Phase 2Post Stroke DepressionJun 2027
Acacia PharmaRemimazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2Pediatric ALL; Benzodiazepines; Cataract Surgery; Sedation for Diagnostic Gastroscopy …Oct 2027
Stanford UniversityZolpidem
GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator
GABRA1, GABRG2, GABRB1Phase 2AutismApr 2028
University of California, Los AngelesEszopiclone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2Obstructive Sleep ApneaAug 2028
M.D. Anderson Cancer CenterLorazepam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2DeliriumDec 2028
Insel Gruppe AG, University Hospital BernMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2Anxiety–
University Hospital, Grenoblemidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2Neurocognitive Disorders–
Yale UniversityEthanol
GABA-A receptor potentiator and NMDA receptor antagonist
GABRA1, GRIN1Phase 1CannabisDec 2026
CAMC Health SystemMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 1AnesthesiaApr 2027
Qianfoshan HospitalRemimazolam Besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 1Chronic Kidney DiseasesJun 2027
Makassed General HospitalMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 1Healthy Female Volunteer–
Beijing Tiantan HospitalY-4 tablet
Fixed-dose combination of pregabalin (GABA analog/anticonvulsant) and riluzole (glutamate
GABRA1, SOD1Phase 1Healthy Male and Female Subjects–
Umecrine Cognitiongolexanolone
Positive allosteric modulator of GABA-A receptor
GABRA1Phase 1Primary Biliary Cholangitis (PBC)–

Conditions

Anesthesia (6) Cannabis (3) Partial Epilepsy (2) Healthy Male and Female Subjects (2) Lung Cancer (2) Hepatocellular Carcinoma (2) Ovarian Cancer (2) Cholelithiasis (2) Anxiety (2) Laceration of Skin (2) Major Depressive Disorder (MDD) (1) Epilepsies, Partial (1)

Modalities

small molecule (56)

Companies

University of California, Los Angeles (3) Yale University (2) Ono Pharmaceutical (2) Kaohsiung Medical University Chung-Ho Memorial Hospital (2) Stanford University (2) Xi'an Aerospace General Hospital (2) VA Office of Research and Development (2) Medical University of South Carolina (2) Seaport Therapeutics (1) University Hospital, Grenoble (1) Southeast University, China (1) Duke University (1) Seoul National University Hospital (1) Lipocine (1) Beijing Tiantan Hospital (1) University Hospitals Cleveland Medical Center (1) Insel Gruppe AG, University Hospital Bern (1) Rawalpindi Institute of Cardiology (1) David Lyubashevsky (1) UCB Biopharma SRL (1)

Related targets

GABRG2 (45) GABRB2 (41) GABRB3 (36) GABRA4 (36) GLRA1 (5) GLRB (5) GABRB1 (4) GABRA2 (2) GABRA3 (2) GRIN1 (1) SOD1 (1) HTR1A (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.